APA (7th ed.) Citation

Bühler, K., Roeder, C., Schwarze, J., Lispi, M., Allignol, A., D'Hooghe, T., . . . Fischer, R. (2022). POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP) Based on DATA from a Large German Registry. Value in Health, 25(1), S108. https://doi.org/10.1016/j.jval.2021.11.514

Chicago Style (17th ed.) Citation

Bühler, K., C. Roeder, JE Schwarze, M. Lispi, A. Allignol, T. D'Hooghe, E. Falla, V. Lukyanov, and R. Fischer. "POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP) Based on DATA from a Large German Registry." Value in Health 25, no. 1 (2022): S108. https://doi.org/10.1016/j.jval.2021.11.514.

MLA (9th ed.) Citation

Bühler, K., et al. "POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP) Based on DATA from a Large German Registry." Value in Health, vol. 25, no. 1, 2022, p. S108, https://doi.org/10.1016/j.jval.2021.11.514.